Matthew C. Hill, Chief Financial Officer at PDS Biotechnology Corp (PDSB), bought 3,000 shares at $9.00 ($27K) on 2021-12-13, disclosed to the SEC on 2021-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.90 | 400 | $4K | 13.2% |
| 2 | $9.00 | 100 | $900 | 3.3% |
| 3 | $9.00 | 2,500 | $23K | 83.5% |
| Total | $8.99 avg | 3,000 | $27K | 100% |
| Filing → |
| APYX | BUY | 2023-12-14 | $5K | — | Filing → |
| SSKN | BUY | 2018-06-14 | $20K | — | Filing → |
| VLCR | BUY | 2008-05-28 | $4K | — | Filing → |